Regeneron Pharmaceuticals
REGN
REGN
603 hedge funds and large institutions have $35.9B invested in Regeneron Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 229 increasing their positions, 201 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more funds holding
Funds holding: 578 → 603 (+25)
0.94% more ownership
Funds ownership: 69.06% → 70% (+0.94%)
9% less call options, than puts
Call options by funds: $1.3B | Put options by funds: $1.44B
Holders
603
Holding in Top 10
22
Calls
$1.3B
Puts
$1.44B
Top Buyers
| 1 | +$763M | |
| 2 | +$262M | |
| 3 | +$233M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$204M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$118M |
Top Sellers
| 1 | -$292M | |
| 2 | -$266M | |
| 3 | -$144M | |
| 4 |
Two Sigma Advisers
New York
|
-$91.1M |
| 5 |
Renaissance Technologies
New York
|
-$89.9M |